Should cannabis products in California come with warnings about rare, adverse reactions for people living with schizophrenia and other mental illnesses, or does it fuel false or exaggerated beliefs about cannabis?
Senate Bill 1097, the Cannabis Right to Know Act, was introduced February 16 by Sen. Richard Pan, and is sponsored by the Public Health Institute, a nonprofit. On June 21, it was amended in the Committee on Business and Professions, as support for the bill gained steam.
Some researchers say people must already have a predisposition for a mental disorder like schizophrenia for these types of negative reactions to
Read full article on High Times
